ADC Therapeutics SA (ADCT)
NYSE: ADCT · IEX Real-Time Price · USD
4.340
-0.100 (-2.25%)
At close: Apr 26, 2024, 4:00 PM
4.460
+0.120 (2.76%)
After-hours: Apr 26, 2024, 7:51 PM EDT
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $359.41 million as of April 26, 2024. Its market cap has increased by 90.87% in one year.
Market Cap
359.41M
Enterprise Value
205.19M
1-Year Change
90.87%
Ranking
Category
Stock Price
$4.34
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $1.98B to $359.41M, a decrease of -81.87%. That is a compound annual growth rate of -35.12%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 365.20M | -7.12% |
Apr 24, 2024 | 393.20M | -3.82% |
Apr 23, 2024 | 408.80M | 6.18% |
Apr 22, 2024 | 385.00M | -0.85% |
Apr 19, 2024 | 388.30M | -0.82% |
Apr 18, 2024 | 391.50M | -4.04% |
Apr 17, 2024 | 408.00M | 11.72% |
Apr 16, 2024 | 365.20M | 1.59% |
Apr 15, 2024 | 359.50M | -0.44% |
Apr 12, 2024 | 361.10M | -6.21% |
Apr 11, 2024 | 385.00M | -0.62% |
Apr 10, 2024 | 387.40M | -1.48% |
Apr 9, 2024 | 393.20M | -6.09% |
Apr 8, 2024 | 418.70M | 1.80% |
Apr 5, 2024 | 411.30M | 6.17% |
Apr 4, 2024 | 387.40M | 6.31% |
Apr 3, 2024 | 364.40M | 2.79% |
Apr 2, 2024 | 354.50M | -2.93% |
Apr 1, 2024 | 365.20M | -1.11% |
Mar 28, 2024 | 369.30M | 6.89% |
Mar 27, 2024 | 345.50M | -3.44% |
Mar 26, 2024 | 357.80M | 3.56% |
Mar 25, 2024 | 345.50M | -7.47% |
Mar 22, 2024 | 373.40M | -1.53% |
Mar 21, 2024 | 379.20M | -2.54% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Harrow Health | 372.37M |
Heron Therapeutics | 368.31M |
Aquestive Therapeutics | 366.17M |
Cartesian Therapeutics | 365.20M |
Zynex | 360.63M |
Corbus Pharmaceuticals Holdings | 359.39M |
Amarin Corporation | 357.68M |
Aura Biosciences | 357.42M |